Mahathir Bayena

Biodexa (NASDAQ:BDRX) announced that 87 of a planned 168 subjects have been enrolled in its registrational Phase 3 Serenta trial evaluating eRapa in Familial Adenomatous Polyposis (FAP).

Galmed Pharmaceuticals (NASDAQ:GLMD) announced that its wholly owned subsidiary Colospan completed a first-in-human feasibility study of a colon tissue quality assessment platform in 32 colorectal cancer patients undergoing elective surgery.

ZIM Integrated Shipping Services (NYSE:ZIM) reported second-quarter 2026 revenue of $1.78 billion, up 9% year over year, with net income increasing to $64 million from $24 million.

Target (NYSE:TGT) reported second-quarter 2026 net sales of $26.5 billion, up 5.3% year over year, as comparable sales increased 3.8% with traffic growth of 3.6%.

Full Truck Alliance (NYSE:YMM) reported Q2 2026 net revenue of RMB3.38 billion, up 4.4% year over year, as freight matching services drove higher revenue.

Itaú Unibanco warned that moving deposits into stablecoins too quickly could affect Brazil’s credit system.

SHAPE Australia (ASX:SHA) reported full-year revenue exceeding $1.2 billion for the financial year ended June 30.

Maya Protocol halted its network after an attacker exploited a vulnerability and drained about $1.7 million.

Hansen Technologies (ASX:HSN) reported a 1.5% revenue decline to $386.5 million as upfront licence fees dropped.

Bitcoin (CRYPTO:BTC) miners shifting into AI and high-performance computing have secured stronger market valuations.